Dow Chemical says its third-quarter earnings fell 28 percent on a slew of one-time charges. Its adjusted results still topped Wall Street’s expectations. Get the full story »
Filed under: Earnings
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Oct. 28, 2010 at 5:43 a.m.
Comments Off
Filed under: Agriculture/Farming, Earnings, International, M&A Potash Corp. profit tops expectations
Potash Corp., the world’s top fertilizer maker, steamrolled quarterly earnings expectations on Thursday on the back of stronger potash demand and higher prices for its nitrogen- and phosphate-based nutrients.
The Canadian fertilizer maker is currently battling a $39 billion hostile bid from BHP Billiton. Potash Corp has flatly rejected BHP’s bid and launched a lawsuit against the Anglo-Australian miner in an attempt to stymie a takeover. Get the full story »
Allstate tumbles after 3Q earnings miss estimates
Allstate Corp.’s shares tumbled in late trading after the insurer’s third-quarter profit missed analyst estimates.
Operating earnings of $452 million, or 83 cents a share, were down 16 percent from the same period a year earlier as Allstate’s homeowners unit reported an underwriting loss on costs tied to settling a class-action lawsuit. Analysts surveyed by Thomson Reuters had expected an operating profit of 98 cents a share. Get the full story »
Morningstar 3Q falls below Street expectations
Chicago data-tracking firm Morningstar Inc. reported quarterly earnings below Wall Street estimates, hurt by higher expenses, and said it would pay a dividend for the first time.
Net income for the third quarter was $20.8 million, or 41 cents a share, compared with $22.5 million, or 45 cents a share a year earlier. Get the full story »
Wintrust Financial Q3 beats Street
Wintrust Financial Corp. reported a larger-than-expected increase in quarterly profit, helped by a lower provision to cover bad loans.
For the third quarter, net income was $15.2 million, or 47 cents a share, compared with $27.3 million, or $1.07 a share, in the year-ago period. Get the full story »
Molex shares sink on lower outlook
Shares of Molex Inc. were down 7 percent in early trading Wednesday, a day after the Lisle-based company reported better-than-expected earnings bur warned that its second-quarter earnings would be below estimates. Get the full story »
Molex shares fall on Q2 earnings disappointment
Electronic connector maker Molex Inc. posted a quarterly profit that beat market estimates, partly helped by new product launches and strong demand, but forecast second-quarter earnings below estimates, sending its shares down 4 percent in after-market trade. Get the full story »
Panera Q3 profit matches view, shares fall
Panera Bread Co. reported third-quarter profit that matched analysts’ view, and shares fell 4.6 percent despite its better-than-expected profit targets for the fourth quarter and next year. Get the full story »
Tellabs profit doubles in 3Q, shares stumble
Shares of Tellabs were down more than 14 percent in afternoon trading Tuesday after the communications equipment maker reported a strong gain in third-quarter profit but its fourth-quarter projections worried investors.
Naperville-based Tellabs said it earned $57 million, or 15 cents a share, in the third quarter, compared with $29 million, or 7 cents a share, in the year-ago period. Revenues during the quarter rose 10 percent to $429 million. Get the full story »
Drugmaker Bristol-Myers sees 3Q profit dip
Bristol-Myers Squibb Co. posted a slight decline in third-quarter profit Tuesday as its restrained spending was offset by flat sales of its drugs, lower income from its partners and bigger discounts to government because of the health care overhaul.
Oct. 26, 2010 at 10:02 a.m.
Filed under: Chicago executives, Earnings, Management, Personnel moves, Pharmaceuticals Hospira board has ’short list’ for new CEO
Hospira Inc. chief executive officer Christopher Begley said this morning that the company’s board will be interviewing candidates to succeed him in the next two months from a newly-created “short list.”
Begley, the top executive of the Lake Forest-based generic drug and device maker, told Wall Street analysts on the company’s third-quarter earnings call that “several dozen” applicants for his job have been pared down to a “short list.” Get the full story »
OptionsXpress beats Street on lower expenses
Online brokerage optionsXpress Holdings Inc. reported quarterly profit above expectations on lower expenses and taxes. Get the full story »
PrivateBancorp swings to profit in 3Q
PrivateBancorp, Inc., said it returned to profitability in the third quarter as a result of new loan growth. The Chicago-based bank on Tuesday reported net income of $4.5 million, or 6 cents a share for the third quarter, compared with a net loss of $31.2 million, or 68 cents a share, in the year-ago period. Get the full story »
Hospira profits tumble over lost cancer drug sales
Hospira Inc.’s third-quarter profit tumbled 40 percent largely due to the loss of U.S. sales of a generic cancer drug the company cannot sell due to a patent settlement that is keeping the cheaper version off the market.
The Lake Forest-based maker of generic injectable drugs and medication delivery devices said net income fell to $71.4 million, or 42 cents a share in the third quarter ended Sept. 30. That compares to $116.2 million, or 71 cents in the third quarter of 2009. Get the full story »
